July 19, 2023 Home Bioscience eyes fresh funds With a focus on France and Germany, the company builder is also closing in on its final two targets.
November 06, 2020 Ash 2020 preview – early winners and losers Unveiling of abstracts for December’s haematology meeting sent Crispr up and Allogene down, but the biggest beneficiary was private.
